Catheter-based ultrasound thrombolysis significantly reduces the risk of severe pulmonary embolism

by | Mar 30, 2026 | Health, Research

High-risk patients with acute pulmonary embolism benefit from ultrasound-assisted, catheter-based thrombolysis. This is shown by the HI-PEITHO study conducted by the Mainz University Medical Center. Compared to treatment with blood thinners alone, the risk of death or life-threatening circulatory collapse was 61 percent lower.

In acute pulmonary embolism, a blood clot blocks pulmonary vessels and can severely impair the heart’s pumping function. About 15 percent of those affected die from it. Although systemic thrombolytics are effective at dissolving clots, they increase the risk of severe bleeding. For this reason, they have so far usually only been used in the most severe cases.

In the minimally invasive procedure, a drug to dissolve blood clots is administered directly into the pulmonary arteries via catheter. | Copyright: UM/Canva
In the minimally invasive procedure, a drug to dissolve blood clots is administered directly into the pulmonary arteries via catheter. | Copyright: UM/Canva

In the HI-PEITHO study, a catheter was advanced through a vein in the groin into the pulmonary arteries in patients with medium to high risk. A thrombolytic drug was delivered into the clot in a targeted manner and additional ultrasound energy was used to accelerate the degradation. This shortened the treatment time and reduced the dose of medication.

The randomized multicenter study involved 544 adult patients from Germany, seven other European countries and the USA. Within the first seven days after treatment, the primary endpoint – death from pulmonary embolism or life-threatening cardiovascular collapse – occurred in 4 percent in the catheter group and 10.3 percent in the control group with anticoagulation alone. Severe bleeding complications were rare overall; Cerebral haemorrhages did not occur in any group.

The study is considered the largest of its kind in this field to date. It was initiated and scientifically co-led by the Mainz University Medical Center, in partnership with the Pulmonary Embolism Response Team (PERT) Consortium in the USA and the study sponsor Boston Scientific.

The results were published in the “New England Journal of Medicine” on March 28, 2026 and presented at the American College of Cardiology (ACC.26) congress.

The Mainz University Medical Center is the only supramaximal care facility in Rhineland-Palatinate and treats around 403,000 inpatients and outpatients every year.

Original Paper:

Ultrasound-Facilitated, Catheter-Directed Fibrinolysis for Acute Pulmonary Embolism | New England Journal of Medicine


Editor: X-Press Journalistenbüro GbR

Gender Notice. The personal designations used in this text always refer equally to female, male and diverse persons. Double/triple naming and gendered designations are used for better readability. ected.

X
Ich bin Invi, wie kann ich dir helfen?